Blockchain Transaction Record
Glafabra Therapeutics Secures Exclusive Rights to Novel Vector for Treating Enzyme Deficiency Diseases.
The licensed technology improves the potency of cell gene therapies by increasing the transformation capacity of lentivirus vectors. Dramatic improvements in patient outcomes are expected from the resulting higher expression of therapeutic protein.
Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.
Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.
| Details | |
|---|---|
| Chain | Ethereum Blockchain via Polygon |
| Transaction ID | 0x029095205a238d2541545b80ac177c13435999b68461c6cb405794df2aee7fdc |
| Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
| NWAI Digital Fingerprint | 1400-fe44fac9afebca21ab058d6f59d15980 |
| Registration Timestamp | 2025-01-13 22:46:00.415628 |